Malaria represents one of the most serious threats to human health worldwide, and preventing and curing this parasitic disease still depends predominantly on the administration of a small number of ...

Australian researchers have worked with global phamarceutical company MSD to co-develop a new antimalarial drug candidate designed to address the growing challenge of drug resistance and potentially ...

Researchers led by teams at the University of California, Riverside (UCR), the University of California, Irvine, and the Yale School of Medicine have developed a compound that they found to be ...

Researchers have developed a new antimalarial drug candidate designed to address the growing challenge of drug resistance and potentially reduce ...

This cartoon shows the newly identified mefloquine binding site causing the changes in the ribosome's dynamics which promote read-through of the premature stop codons. The main interactions are shown ...

The antimalarial drug mefloquine could help treat genetic diseases such as cystic fibrosis, Duchenne muscular dystrophy, as well as some cancers. In these diseases, a mutation in the genetic code ...

Researchers have developed a new antimalarial drug candidate designed to address the growing challenge of drug resistance and ...